(4) See Table 9.3. The amide bond and the carboxylic acid group make the conjugate
more water soluble than the original aromatic acid.
(5) (a)
CH 3
N CH 3
COOC 2 H 5
Hydroxylation of the benzene ring.
Hydrolysis of the ester to
Cleavage of the N-CH 3 bond to
N
+
COOH
C 2 H 5 OH
HCHO
Ph COOC 2 H 5
+
N
H
(b)
N=NNNH 2 =N
NH 2 H 2 N NH 2
NHCOCH 3
Hydroxylation of the benzene ring.
Acylation
Reductive cleavage
(6) (a) To inactive the drug. Metabolism to inert metabolites that are sufficiently water
soluble to be readily excreted via the kidney.
(b) Thea-carbon of an ethyl group t-amine is hydroxylated and cleaved to form
methanal and the N-methylaminobenzene. Methanal could be excreted via the
lungs or be metabolized further to ethanoic acid. The N-methylaminobenzene
could be metabolically oxidized to the corresponding N-hydroxy compound or
dealkylated to aminobenzene and methanal.
(7) (a) A is metabolized faster than the drug, so it does not accumulate in the body.
(b) B to C is the main metabolic route, since this is a very much faster process than
BtoF.
(c) C to D; C will accumulate in the body. If C is pharmacologically active this
could pose potential clinical problems for a patient.
(8) To avoid fatal over-doses.
(9) See Section 9.8.3. Use a N-methyldihydropyridine derivative as carrier. This carrier
would require a substituent group that can bond to the dopamine diethanoate. The
best group for this purpose is probably a carboxylic acid group, since amides are
slowly hydrolysed. This means the prodrug has a good chance of reaching the
blood–brain barrier in sufficient quantity to be effective. Once the prodrug has
ANSWERS TO QUESTIONS 269